Immunocore Holdings (IMCR) EBIT Margin (QoQ) (2021 - 2026)

Immunocore Holdings (IMCR) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immunocore Holdings 1.80 Bn 957.43 Mn 106.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2,567.00
Dec 31, 2025 -1,193.00
Sep 30, 2025 827.00
Jun 30, 2025 -1,133.00
Mar 31, 2025 1,929.00
Dec 31, 2024 -1,255.00
Sep 30, 2024 1,065.00
Jun 30, 2024 1,633.00
Mar 31, 2024 -1,327.00
Dec 31, 2023 -249.00
Sep 30, 2023 1,122.00
Jun 30, 2023 -614.00
Mar 31, 2023 1,957.00
Dec 31, 2022 -6,143.00
Sep 30, 2022 6,642.00
Dec 31, 2021 -5,137.00